Unconfigured Ad

Collapse

Relevant events or scientific conferences that may be of interest to the community. (Mgmt reserves right to limit commercial content without approval.)

Forums Topics Posts Last Post
No forums found.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Filter
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by Biotexcel, 03-10-2019, 10:12 AM
0 responses
4,112 views
0 reactions
Last Post Biotexcel  
Started by hollystephens723, 03-01-2019, 01:57 PM
0 responses
2,467 views
0 reactions
Last Post hollystephens723  
Started by hollystephens723, 02-26-2019, 10:55 AM
1 response
2,084 views
0 reactions
Last Post michealsclark  
Started by Physalia-courses, 02-14-2019, 07:41 AM
0 responses
11 views
0 reactions
Last Post Physalia-courses  
Started by Physalia-courses, 02-14-2019, 07:08 AM
0 responses
2,202 views
0 reactions
Last Post Physalia-courses  
Started by Physalia-courses, 02-14-2019, 06:57 AM
0 responses
2,599 views
0 reactions
Last Post Physalia-courses  
Started by hollystephens723, 02-13-2019, 10:37 AM
0 responses
2,143 views
0 reactions
Last Post hollystephens723  
Started by hollystephens723, 02-11-2019, 09:15 AM
0 responses
2,544 views
0 reactions
Last Post hollystephens723  
Started by r.rosati, 01-31-2019, 11:54 AM
1 response
2,013 views
0 reactions
Last Post r.rosati  
Started by SIB Swiss Bioinformatics, 01-23-2019, 02:57 AM
0 responses
2,821 views
0 reactions
Last Post Bynarden  
No topics found.
  • Filter
  • Time
Clear All
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.

Recent Articles

Collapse

  • mylaser
    Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by mylaser
    Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
    If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
    This guide explains everything you need to know about...
    Yesterday, 01:13 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...